Trial Outcomes & Findings for Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C (NCT NCT01707030)
NCT ID: NCT01707030
Last Updated: 2025-03-21
Results Overview
The number of days on which alcohol was consumed beyond recommended levels in the last 30 days.
COMPLETED
NA
138 participants
Baseline, 3 months, and 6 months
2025-03-21
Participant Flow
Participant milestones
| Measure |
Web-Based BAI Arm
Receiving a web-based brief intervention for alcohol problems
Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms.
|
Usual Care Arm
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
|---|---|---|
|
Overall Study
STARTED
|
67
|
71
|
|
Overall Study
COMPLETED
|
56
|
54
|
|
Overall Study
NOT COMPLETED
|
11
|
17
|
Reasons for withdrawal
| Measure |
Web-Based BAI Arm
Receiving a web-based brief intervention for alcohol problems
Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms.
|
Usual Care Arm
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
|---|---|---|
|
Overall Study
Death
|
1
|
1
|
|
Overall Study
Withdrawal by Subject
|
2
|
3
|
|
Overall Study
Lost to Follow-up
|
8
|
13
|
Baseline Characteristics
Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C
Baseline characteristics by cohort
| Measure |
Intervention: Computer-Based Brief Alcohol Intervention
n=67 Participants
Receiving a web-based brief intervention for alcohol problems
Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms.
Intervention participants will also receive usual care.
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
Control: Treatment as Usual
n=71 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
Total
n=138 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
42 Participants
n=5 Participants
|
40 Participants
n=7 Participants
|
82 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
25 Participants
n=5 Participants
|
31 Participants
n=7 Participants
|
56 Participants
n=5 Participants
|
|
Age, Continuous
|
64 years
STANDARD_DEVIATION 8.682 • n=5 Participants
|
63 years
STANDARD_DEVIATION 7.212 • n=7 Participants
|
63.5 years
STANDARD_DEVIATION 8.023 • n=5 Participants
|
|
Sex: Female, Male
Female
|
5 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
62 Participants
n=5 Participants
|
71 Participants
n=7 Participants
|
133 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Asian and/or Pacific Islander
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Black/African Amerian
|
21 Participants
n=5 Participants
|
20 Participants
n=7 Participants
|
41 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · White/Caucasion, not of Hispanic origin
|
25 Participants
n=5 Participants
|
28 Participants
n=7 Participants
|
53 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Hispanic
|
9 Participants
n=5 Participants
|
15 Participants
n=7 Participants
|
24 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Other
|
6 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
12 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · Declined to State/Unknown
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race/Ethnicity · American Indian or Alaskan Native
|
3 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
67 Participants
n=5 Participants
|
71 Participants
n=7 Participants
|
138 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Baseline, 3 months, and 6 monthsPopulation: Not all participants were able to complete all follow-ups in their entirety. We used an analytical approach that used all available data for the participants for the regression analysis even if participants did not complete all the follow-ups.
The number of days on which alcohol was consumed beyond recommended levels in the last 30 days.
Outcome measures
| Measure |
BAI Arm
n=67 Participants
Receiving a web-based brief intervention for alcohol problems
Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms.
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
Usual Care
n=70 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
|---|---|---|
|
Change in Days of Unhealthy Alcohol Consumption
Baseline Days of Unhealthy Alcohol Consumption
|
5.46 Unhealthy drinking days in last 30
Standard Deviation 9.24
|
7.16 Unhealthy drinking days in last 30
Standard Deviation 10.66
|
|
Change in Days of Unhealthy Alcohol Consumption
3-mo Days of Unhealthy Alcohol Consumption
|
2.72 Unhealthy drinking days in last 30
Standard Deviation 6.69
|
5.56 Unhealthy drinking days in last 30
Standard Deviation 10.68
|
|
Change in Days of Unhealthy Alcohol Consumption
6-mo Days of Unhealthy Alcohol Consumption
|
2.29 Unhealthy drinking days in last 30
Standard Deviation 6.37
|
4.78 Unhealthy drinking days in last 30
Standard Deviation 9.91
|
PRIMARY outcome
Timeframe: Baseline, 3 months, and 6 monthsPopulation: Not all participants were able to complete all questions and/or follow-ups in their entirety. We used an analytical approach that used all available data for the participants for the regression analysis even if participants did not complete all the follow-ups.
The number of days on which alcohol was consumed at any level in the last 30 days.
Outcome measures
| Measure |
BAI Arm
n=67 Participants
Receiving a web-based brief intervention for alcohol problems
Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms.
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
Usual Care
n=71 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
|---|---|---|
|
Change in Drinking Days
Baseline drinking days
|
9.39 Number of drinking days in last 30
Standard Deviation 10.44
|
12.41 Number of drinking days in last 30
Standard Deviation 11.47
|
|
Change in Drinking Days
3-mo drinking days
|
5.20 Number of drinking days in last 30
Standard Deviation 8.09
|
7.77 Number of drinking days in last 30
Standard Deviation 10.78
|
|
Change in Drinking Days
6-mo drinking days
|
4.61 Number of drinking days in last 30
Standard Deviation 7.66
|
8.26 Number of drinking days in last 30
Standard Deviation 10.67
|
SECONDARY outcome
Timeframe: Baseline, 3 months, and 6 monthsPopulation: Not all participants were able to complete all questions and/or follow-ups in their entirety. We used an analytical approach that used all available data for the participants for the regression analysis even if participants did not complete all the follow-ups.
The number of standard drinks (0.5 ounce ethanol equivalent) consumed on those days that an individual drank in the last 30 days.
Outcome measures
| Measure |
BAI Arm
n=67 Participants
Receiving a web-based brief intervention for alcohol problems
Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms.
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
Usual Care
n=71 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
|---|---|---|
|
Change in Drinks Per Drinking Day
Baseline Drinks per Drinking Day
|
3.57 Drinks per Drinking Day
Standard Deviation 3.90
|
3.72 Drinks per Drinking Day
Standard Deviation 3.69
|
|
Change in Drinks Per Drinking Day
3-mo Drinks per Drinking Day
|
2.29 Drinks per Drinking Day
Standard Deviation 2.47
|
2.17 Drinks per Drinking Day
Standard Deviation 2.17
|
|
Change in Drinks Per Drinking Day
6-mo Drinks per Drinking Day
|
1.98 Drinks per Drinking Day
Standard Deviation 2.85
|
1.87 Drinks per Drinking Day
Standard Deviation 1.90
|
SECONDARY outcome
Timeframe: Baseline, 3 months, and 6 monthsPopulation: Not all participants were able to complete all questions and/or follow-ups in their entirety. We used an analytical approach that used all available data for the participants for the regression analysis even if participants did not complete all the follow-ups.
Symptoms of psychological distress will be measured using the Patient Health Questionnaire (PHQ-9). The PHQ-9 provides an assessment of depression severity. The minimum value is 0 and the maximum value is 27. Lower scores are better. The reliability, validity, and clinical utility of the PHQ-9 instrument are well-established.
Outcome measures
| Measure |
BAI Arm
n=67 Participants
Receiving a web-based brief intervention for alcohol problems
Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms.
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
Usual Care
n=71 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
|---|---|---|
|
Change in Symptoms of Psychological Distress (PHQ-9)
Baseline PHQ-9
|
6.00 score on a scale
Standard Deviation 5.70
|
6.68 score on a scale
Standard Deviation 5.67
|
|
Change in Symptoms of Psychological Distress (PHQ-9)
3-mo PHQ-9
|
6.03 score on a scale
Standard Deviation 5.65
|
6.91 score on a scale
Standard Deviation 6.86
|
|
Change in Symptoms of Psychological Distress (PHQ-9)
6-mo PHQ-9
|
5.57 score on a scale
Standard Deviation 5.07
|
7.44 score on a scale
Standard Deviation 7.48
|
SECONDARY outcome
Timeframe: Baseline, 3 months, and 6 monthsPopulation: Not all participants were able to complete all questions and/or follow-ups in their entirety. We used an analytical approach that used all available data for the participants for the regression analysis even if participants did not complete all the follow-ups.
The Short Form-12 (SF-12) is a 12-item health survey based on the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) designed to assess two component health status summary scales (physical and mental component summaries) in the general U.S. population . The SF-12 has demonstrated good internal consistency reliability and construct validity. This reflects the physical health component of the SF-12. Scores range from 0-100 and higher scores are better.
Outcome measures
| Measure |
BAI Arm
n=67 Participants
Receiving a web-based brief intervention for alcohol problems
Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms.
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
Usual Care
n=71 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
|---|---|---|
|
Change in SF-12 Physical Health Composite
Baseline SF-12 Health
|
40.43 score on a scale
Standard Deviation 12.20
|
40.49 score on a scale
Standard Deviation 11.43
|
|
Change in SF-12 Physical Health Composite
3mo SF-12 Health
|
39.92 score on a scale
Standard Deviation 12.25
|
41.59 score on a scale
Standard Deviation 12.30
|
|
Change in SF-12 Physical Health Composite
6mo SF-12 Health
|
42.21 score on a scale
Standard Deviation 10.43
|
40.75 score on a scale
Standard Deviation 12.45
|
SECONDARY outcome
Timeframe: Baseline and 12 monthsPopulation: These are the same individuals enrolled in the clinical trial from whom the primary outcomes were assessed.
Total costs in dollars of all VA and non-VA inpatient, outpatient and pharmacy costs.
Outcome measures
| Measure |
BAI Arm
n=53 Participants
Receiving a web-based brief intervention for alcohol problems
Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms.
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
Usual Care
n=54 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
|---|---|---|
|
Change in Additional Care
|
42412 US Dollars
Standard Error 5381
|
51667 US Dollars
Standard Error 8611
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, 3 months, and 6 monthsPopulation: Not all participants were able to complete all questions and/or follow-ups in their entirety. We used an analytical approach that used all available data for the participants for the regression analysis even if participants did not complete all the follow-ups.
The Short Form-12 (SF-12) is a 12-item health survey based on the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) designed to assess two component health status summary scales (physical and mental component summaries) in the general U.S. population. The SF-12 has demonstrated good internal consistency reliability and construct validity. This reflects the mental health component of the SF-12. Scores range from 0-100 and higher scores are better.
Outcome measures
| Measure |
BAI Arm
n=67 Participants
Receiving a web-based brief intervention for alcohol problems
Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms.
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
Usual Care
n=71 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
|---|---|---|
|
Change in SF-12 Mental Health Composite
Baseline SF-12 Mental Health
|
49.10 score on a scale
Standard Deviation 12.72
|
48.91 score on a scale
Standard Deviation 11.87
|
|
Change in SF-12 Mental Health Composite
3mo SF-12 Mental Health
|
50.83 score on a scale
Standard Deviation 9.94
|
49.25 score on a scale
Standard Deviation 11.62
|
|
Change in SF-12 Mental Health Composite
6 mo SF-12 Mental Health
|
50.63 score on a scale
Standard Deviation 10.59
|
48.51 score on a scale
Standard Deviation 12.77
|
Adverse Events
Intervention: Web-Based BAI Arm
Control: Usual Care Arm
Serious adverse events
| Measure |
Intervention: Web-Based BAI Arm
n=67 participants at risk
Receiving a web-based brief intervention for alcohol problems
Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms.
|
Control: Usual Care Arm
n=71 participants at risk
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls
Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
|
|---|---|---|
|
General disorders
Death
|
1.5%
1/67 • Number of events 1 • Adverse event data were collected for 4 years.
|
0.00%
0/71 • Adverse event data were collected for 4 years.
|
|
Renal and urinary disorders
Death
|
0.00%
0/67 • Adverse event data were collected for 4 years.
|
1.4%
1/71 • Number of events 1 • Adverse event data were collected for 4 years.
|
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place